
La Jolla Pharmaceutical Company LJPC
Quartalsbericht 2022-Q2
hinzugefügt 15.08.2022
La Jolla Pharmaceutical Company EV/EBITDA 2011-2026 | LJPC
EV/EBITDA Jährlich La Jolla Pharmaceutical Company
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 10.5 | -4.79 | -0.928 | 0.151 | -5.4 | -3.41 | -3.62 | -8.65 | 0.266 | 0.181 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 10.5 | -8.65 | -1.57 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Esperion Therapeutics
ESPR
|
-2.15 | $ 3.13 | 0.16 % | $ 651 M | ||
|
Exelixis
EXEL
|
18.1 | $ 46.2 | 4.01 % | $ 12.5 B | ||
|
Athira Pharma
ATHA
|
-3.66 | - | - | $ 269 M | ||
|
Fortress Biotech
FBIO
|
-0.152 | $ 2.49 | 1.22 % | $ 69.5 M | ||
|
Fennec Pharmaceuticals
FENC
|
0.832 | $ 6.85 | 1.93 % | $ 196 M | ||
|
Galectin Therapeutics
GALT
|
-1.92 | $ 2.28 | 2.24 % | $ 146 M | ||
|
Galapagos NV
GLPG
|
-26.5 | $ 28.82 | 1.51 % | $ 2.69 B | ||
|
Grifols, S.A.
GRFS
|
13.7 | $ 8.4 | 1.51 % | $ 6.83 B | ||
|
Genprex
GNPX
|
-4.81 | $ 0.89 | 0.28 % | $ 830 K | ||
|
BioNTech SE
BNTX
|
4.1 | $ 94.21 | -1.35 % | $ 27.2 B | ||
|
InflaRx N.V.
IFRX
|
-3.65 | $ 2.37 | 20.05 % | $ 152 M | ||
|
Immuron Limited
IMRN
|
-106 | $ 0.82 | 3.97 % | $ 6.82 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.0315 | - | - | $ 231 M | ||
|
Ionis Pharmaceuticals
IONS
|
-363 | $ 76.34 | 1.45 % | $ 12.2 B | ||
|
Innate Pharma S.A.
IPHA
|
-6.65 | $ 1.49 | 3.83 % | $ 235 M | ||
|
INmune Bio
INMB
|
-3.64 | $ 1.51 | -1.95 % | $ 37.4 M | ||
|
Kamada Ltd.
KMDA
|
-386 | $ 8.31 | 1.22 % | $ 260 M | ||
|
Kymera Therapeutics
KYMR
|
-21.5 | $ 85.92 | 3.88 % | $ 7.26 B | ||
|
Kazia Therapeutics Limited
KZIA
|
-1.24 | $ 12.98 | -3.53 % | $ 1.72 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
-21.1 | $ 23.02 | 2.98 % | $ 3.81 B | ||
|
Liquidia Corporation
LQDA
|
-6.02 | $ 41.73 | 3.97 % | $ 3.59 B | ||
|
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 3.56 | 1.71 % | $ 5.86 M | ||
|
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Mirum Pharmaceuticals
MIRM
|
-3.46 | $ 106.77 | 0.9 % | $ 5.36 B | ||
|
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
MannKind Corporation
MNKD
|
-32.8 | $ 3.88 | 35.49 % | $ 1.19 B | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Mereo BioPharma Group plc
MREO
|
-25.2 | $ 0.27 | -3.84 % | $ 660 M | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
-1.56 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-4.86 | $ 23.63 | 0.9 % | $ 3.01 B | ||
|
Nanobiotix S.A.
NBTX
|
-4.62 K | $ 39.36 | 13.2 % | $ 286 B | ||
|
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M |